{
  "id": 92295,
  "title": "AstraZeneca Investors See Little Logic in Bristol Tie-Up",
  "url": "https://urgent.news/2026/08/03/astrazeneca-investors-see-little-logic-in-bristol-tie-up",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-03T16:37:32.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/videos/2026-08-03/astrazeneca-investors-see-little-logic-in-bristol-tie-up-video"
  },
  "original_language": "en",
  "account": null,
  "summary": "AstraZeneca Plc investors had a clear message for the UK drugmaker on Monday: they don’t like the idea of a $400 billion merger with Bristol-Myers Squibb Co. Bloomberg Intelligence's Director of Research, Sam Fazeli joins to discuss. (Source: Bloomberg)",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}